Novo Nordisk Cuts Wegovy Prices in Half While Its Stock Sits Near a 52-Week Low [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
Novo Nordisk will slash prices on its flagship drugs to $675 monthly starting January 2027. Novo guided -5% to -13% sales growth for 2026. Novo Nordisk fell 53.8% over the past year to $39.63. Novo now trades at 13x trailing earnings. A recent study identified one single habit that doubled Americans' retirement savings and moved retirement from dream, to reality. Read more here After finding itself some unwanted attention this week, Novo Nordisk NYSE:NVO ) has dropped 22% in the past week and 56% over the past year, now sitting near its 52-week low. As a result, Reddit sentiment has followed along with this downward shift, sliding from a quarterly average of 56 to a weekly average of 43 after two damaging stories hit in rapid succession: a clinical trial failure and a plan to cut prices on flagship drugs. 24/7 Wall St. · 24/7 Wall St. Novo Nordisk (NVO) shows a neutral social sentiment score of 52 as of February 24, 2026, despite a 1-year stock decline of 53.8% to $39.63,
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Forget Altimmune: This Proven Obesity-Drug Giant Is the Better Weight-Loss Play [Yahoo! Finance]Yahoo! Finance
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVOPR Newswire
- PatentVest Releases New Report on The Oral Small-Molecule GLP-1 Patent Race [Yahoo! Finance]Yahoo! Finance
- Lilly's GLP-1 pill tops Novo's Rybelsus in head-to-head trial [Yahoo! Finance]Yahoo! Finance
- Walgreens Virtual Healthcare Adds Weight Management Services to Support Patients on Their Weight Loss Journey [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 2/3/26 - Beat
NVO
Sec Filings
- 2/23/26 - Form 6-K
- 2/23/26 - Form 6-K
- 2/20/26 - Form 6-K
- NVO's page on the SEC website